search
Back to results

Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study (TRH)

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Renin treatment-guided Therapeutics
Referral Hypertension specialist
Aldosterone Antagonist
Sponsored by
Medical University of South Carolina
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypertension focused on measuring Hypertension

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinical diagnosis of Treatment Resistant Hypertension (TRH)
  • On three or more hypertensive medications at therapeutic dose
  • BpTRU measurement on two occasions of >135/85 without diabetes or chronic kidney disease or BP >125/75 if diabetes and/or chronic kidney disease.
  • Mean of >10 BP readings of >135/85 mm mercury for those with no diabetes or chronic kidney disease
  • Mean of >10 home BP readings of >125/75 mm mercury for those with diabetes and/or chronic kidney disease.

Exclusion Criteria:

  • Less than 18 years of age
  • Refuses or incompetent to provide consent
  • BP controlled to goal in or outside the clinic
  • Symptomatic or significant orthostatic hypotension (<20/10 on standing)
  • Life-threatening or severe illness
  • Currently on protocol
  • Myocardial Infarction or stroke in the past 6 months
  • Estimated Glomerular Filtration Rate <50 ml/1.7/min.

Sites / Locations

  • AnMed
  • Beaufort Jasper Hampton Comprehensive Health
  • McLeod Family Medicine Center
  • Family Diagnostics
  • Lovelace Family Medicine
  • Carolina Medical Affiliates
  • Spartanburg Regional Health Services
  • Palmetto Primary Care

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

Aldosterone Antagonist

Referral Hypertension specialist

Renin treatment-guided therapeutics

Renin-guided therapeutics and referral

Arm Description

Prescribe an aldosterone antagonist such as Spironolactone 12.5-25 mg daily as a starting dose with a maximum recommended dose of 50 mg daily.

Referral to a hypertension specialist

Renin treatment-guided therapeutics. A treatment algorithm is provided to guide treatment based upon renin levels.

Renin treatment-guided therapeutics and referral to hypertension specialist. Treatment based upon algorithm for treatment related to renin level in addition to referral to a hypertension specialist.

Outcomes

Primary Outcome Measures

blood pressure control
Blood pressure control will be assessed according to guidelines established by American Heart Association.

Secondary Outcome Measures

Full Information

First Posted
June 17, 2014
Last Updated
July 19, 2018
Sponsor
Medical University of South Carolina
Collaborators
University of South Carolina
search

1. Study Identification

Unique Protocol Identification Number
NCT02167464
Brief Title
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Acronym
TRH
Official Title
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
September 2014
Overall Recruitment Status
Completed
Study Start Date
June 2011 (undefined)
Primary Completion Date
January 2015 (Actual)
Study Completion Date
January 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medical University of South Carolina
Collaborators
University of South Carolina

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Comparative Effectiveness Research using an intent-to-treat approach in 8 clinics in South Carolina. The investigators will assess 4 efficacious approaches to controlling treatment-resistant hypertension (TRH): Aldosterone Antagonist, Referral to Hypertension Specialist, Renin Treatment-Guided Therapeutics, and combination of Hypertension Specialist and Renin Treatment-Guided Therapeutics. Patients with TRH are evaluated with the BpTRU device for an accurate and representative blood pressure measure on two occasions before entry into the study. Qualitative data from focus group discussions with practice staff, and patient surveys and interviews will provide contextual data to help explain why some interventions are more acceptable and successful than others.
Detailed Description
This is Comparative Effectiveness Research conducted in the real world of under-resourced primary care clinics in South Carolina. Four arms of the study are identified with two clinics/arm enrolling and following patients with TRH. The goal is to compare rates of BP control according to American Heart Association guidelines among the 4 arms, along with clinic and patient satisfaction with each approach. Our hypothesis is that defining pathophysiological mechanisms (e.g. renin treatment-guided therapeutics) with or without referral to a hypertension specialist will improve blood pressure control over adding an aldosterone antagonist in eligible patients or just referring patients to a hypertension specialist. This mixed-methods design captures medical and qualitative data to not only describe the outcome of blood pressure control, but to assess the impact of the four interventions on staff and patient satisfaction. Key patient data includes demographics, visits, blood pressure values, medications and laboratory data. Focus group discussions with practice staff before and after the study will document early attitudes toward each arm, any practice changes needed to implement each arm and any burdens of the intervention on the practice. Patient surveys and interviews will assess their satisfaction with each intervention along with their experiences in participating in this research project. Treatment Resistant Hypertension is a common medical condition, and relatively ineffective treatment regimens are a significant contributing factor. The long-term goal is to establish practice and effective approaches for controlling blood pressure and reducing clinical complications and related health disparities.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Hypertension

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
The PI was blinded to clinic and group assignment when he conducted the final statistical analysis.
Allocation
Randomized
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Aldosterone Antagonist
Arm Type
Active Comparator
Arm Description
Prescribe an aldosterone antagonist such as Spironolactone 12.5-25 mg daily as a starting dose with a maximum recommended dose of 50 mg daily.
Arm Title
Referral Hypertension specialist
Arm Type
Active Comparator
Arm Description
Referral to a hypertension specialist
Arm Title
Renin treatment-guided therapeutics
Arm Type
Active Comparator
Arm Description
Renin treatment-guided therapeutics. A treatment algorithm is provided to guide treatment based upon renin levels.
Arm Title
Renin-guided therapeutics and referral
Arm Type
Active Comparator
Arm Description
Renin treatment-guided therapeutics and referral to hypertension specialist. Treatment based upon algorithm for treatment related to renin level in addition to referral to a hypertension specialist.
Intervention Type
Drug
Intervention Name(s)
Renin treatment-guided Therapeutics
Intervention Description
Patients are treated based upon their renin levels according to an approved algorithm.
Intervention Type
Other
Intervention Name(s)
Referral Hypertension specialist
Intervention Description
Patients are referred to a hypertension specialist.
Intervention Type
Drug
Intervention Name(s)
Aldosterone Antagonist
Intervention Description
Spironolactone 12.5 - 25mg daily
Primary Outcome Measure Information:
Title
blood pressure control
Description
Blood pressure control will be assessed according to guidelines established by American Heart Association.
Time Frame
four months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of Treatment Resistant Hypertension (TRH) On three or more hypertensive medications at therapeutic dose BpTRU measurement on two occasions of >135/85 without diabetes or chronic kidney disease or BP >125/75 if diabetes and/or chronic kidney disease. Mean of >10 BP readings of >135/85 mm mercury for those with no diabetes or chronic kidney disease Mean of >10 home BP readings of >125/75 mm mercury for those with diabetes and/or chronic kidney disease. Exclusion Criteria: Less than 18 years of age Refuses or incompetent to provide consent BP controlled to goal in or outside the clinic Symptomatic or significant orthostatic hypotension (<20/10 on standing) Life-threatening or severe illness Currently on protocol Myocardial Infarction or stroke in the past 6 months Estimated Glomerular Filtration Rate <50 ml/1.7/min.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marilyn A Laken, PhD, RN
Organizational Affiliation
Medical University of South Carolina
Official's Role
Principal Investigator
Facility Information:
Facility Name
AnMed
City
Anderson
State/Province
South Carolina
ZIP/Postal Code
29621
Country
United States
Facility Name
Beaufort Jasper Hampton Comprehensive Health
City
Beaufort
State/Province
South Carolina
ZIP/Postal Code
29935
Country
United States
Facility Name
McLeod Family Medicine Center
City
Florence
State/Province
South Carolina
ZIP/Postal Code
29506
Country
United States
Facility Name
Family Diagnostics
City
Holly Hill
State/Province
South Carolina
ZIP/Postal Code
29059
Country
United States
Facility Name
Lovelace Family Medicine
City
Prosperity
State/Province
South Carolina
ZIP/Postal Code
29127
Country
United States
Facility Name
Carolina Medical Affiliates
City
Spartanburg
State/Province
South Carolina
ZIP/Postal Code
29303
Country
United States
Facility Name
Spartanburg Regional Health Services
City
Spartanburg
State/Province
South Carolina
ZIP/Postal Code
29303
Country
United States
Facility Name
Palmetto Primary Care
City
Summerville
State/Province
South Carolina
ZIP/Postal Code
29485
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
De-identified data file is available. Email Suparna Qanungo at MUSC.
Citations:
PubMed Identifier
23321408
Citation
Laken MA, Dawson R, Engelman O, Lovelace O, Way C, Egan BM. Comparative effectiveness research in the "real" world: lessons learned in a study of treatment-resistant hypertension. J Am Soc Hypertens. 2013 Jan-Feb;7(1):95-101. doi: 10.1016/j.jash.2012.12.002.
Results Reference
background
PubMed Identifier
27076600
Citation
Egan BM, Laken MA, Sutherland SE, Qanungo S, Fleming DO, Cook AG, Hester WH, Jones KW, Jebaily GC, Valainis GT, Way CF, Wright MB, Davis RA. Aldosterone Antagonists or Renin-Guided Therapy for Treatment-Resistant Hypertension: A Comparative Effectiveness Pilot Study in Primary Care. Am J Hypertens. 2016 Aug;29(8):976-83. doi: 10.1093/ajh/hpw016. Epub 2016 Apr 13.
Results Reference
result

Learn more about this trial

Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study

We'll reach out to this number within 24 hrs